90 related articles for article (PubMed ID: 22210720)
1. Retinoid X receptor alpha (RXRα) and peroxisome proliferator-activated receptor gamma (PPARγ) expression in breast cancer: an immunohistochemical study.
Ditsch N; Vrekoussis T; Lenhard M; Rühl I; Gallwas J; Weissenbacher T; Friese K; Mayr D; Makrigiannakis A; Jeschke U
In Vivo; 2012; 26(1):87-92. PubMed ID: 22210720
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes.
Holdsworth-Carson SJ; Permezel M; Riley C; Rice GE; Lappas M
Placenta; 2009 Feb; 30(2):176-86. PubMed ID: 19070893
[TBL] [Abstract][Full Text] [Related]
3. PPARgamma expression in breast cancer: clinical value and correlation with ERbeta.
Papadaki I; Mylona E; Giannopoulou I; Markaki S; Keramopoulos A; Nakopoulou L
Histopathology; 2005 Jan; 46(1):37-42. PubMed ID: 15656884
[TBL] [Abstract][Full Text] [Related]
4. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H
Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
[TBL] [Abstract][Full Text] [Related]
6. Functional role of RXRs and PPARgamma in mature adipocytes.
Metzger D; Imai T; Jiang M; Takukawa R; Desvergne B; Wahli W; Chambon P
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):51-8. PubMed ID: 15936932
[TBL] [Abstract][Full Text] [Related]
7. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction.
Rodie VA; Young A; Jordan F; Sattar N; Greer IA; Freeman DJ
J Soc Gynecol Investig; 2005 Jul; 12(5):320-9. PubMed ID: 15979543
[TBL] [Abstract][Full Text] [Related]
8. [Regulatory effects of peroxisome proliferator-activated receptor gamma on the growth of pancreatic carcinoma].
Dong YW; Wang XP; Wu K; Wu LY; Zhang RL
Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):479-82. PubMed ID: 12921608
[TBL] [Abstract][Full Text] [Related]
9. Differential expression and cross-talk of peroxisome proliferator-activated receptor γ and retinoid-X receptor α in urothelial carcinomas of the bladder.
Petta E; Sotiropoulou-Bonikou G; Kourelis K; Melachrinou M; Bonikos DS
J BUON; 2010; 15(4):740-5. PubMed ID: 21229639
[TBL] [Abstract][Full Text] [Related]
10. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
12. [Effects of hexabromocyclododecanes on retinoid X receptor α, pregnane X receptor and peroxisome proliferator-activated receptor γ].
Wan K; Jiang Y; Zhang J; Wang X; Lei Y; Li Y; Xiao Y; Mei S; Zhou J
Wei Sheng Yan Jiu; 2017 May; 46(3):396-403. PubMed ID: 29903249
[TBL] [Abstract][Full Text] [Related]
13. Cloning and expression pattern of peroxisome proliferator-activated receptors, estrogen receptor alpha and retinoid X receptor alpha in the thicklip grey mullet Chelon labrosus.
Raingeard D; Cancio I; Cajaraville MP
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Jan; 149(1):26-35. PubMed ID: 18619562
[TBL] [Abstract][Full Text] [Related]
14. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
15. The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancer.
Watkins G; Douglas-Jones A; Mansel RE; Jiang WG
Oncol Rep; 2004 Aug; 12(2):483-8. PubMed ID: 15254719
[TBL] [Abstract][Full Text] [Related]
16. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
18. Correlation of hormone receptors with Her-2 Neu protein expression and the histological grade in invasive breast cancers in a cohort of Saudi Arabia.
Arafah M
Turk Patoloji Derg; 2012; 28(1):38-43. PubMed ID: 22207430
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
Nakamura Y; Suzuki T; Sugawara A; Arai Y; Sasano H
Pathol Int; 2009 May; 59(5):288-93. PubMed ID: 19432669
[TBL] [Abstract][Full Text] [Related]
20. The effect of prolonged fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast cancer: a prospective study.
Tong LC; Nelson N; Tsourigiannis J; Mulligan AM
Am J Surg Pathol; 2011 Apr; 35(4):545-52. PubMed ID: 21358301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
